80-410 macaque antibody profile -5 agents
Ended Awarded Last action
- Contract number
- HHSN260NIH80284
- Awardee
-
Bioreliance Corporation UEI H3KAG9A26K77
- Awarding agency
-
Office of Acquisition Management and Policy
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,422
Award facts
- Contract value
-
- $5,422.00 Current, with exercised options
- $0.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Not on record Potential, with all options
- Funding agency
- Office of the Director National Institutes of Health, Department of Health and Human Services
- NAICS code
- Not on record
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- 0 offers Simplified Acquisition
- Pricing
- Other
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN260NIH80284?
HHSN260NIH80284 was awarded to Bioreliance Corporation by Office of Acquisition Management and Policy (National Institutes of Health) on October 25, 2006.
How much is contract HHSN260NIH80284 worth?
The government has obligated $5,422 on HHSN260NIH80284.
Which agency awarded contract HHSN260NIH80284?
Office of Acquisition Management and Policy (National Institutes of Health) awarded HHSN260NIH80284, with funding from Office of the Director (National Institutes of Health).
Is contract HHSN260NIH80284 an order under another contract?
Yes. HHSN260NIH80284 is a BPA call under HHSN263199800048997B, a blanket purchase agreement.
Was contract HHSN260NIH80284 competed?
The government received 0 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award